4.5 Article

The muscle quality index and mortality among males and females

期刊

ANNALS OF EPIDEMIOLOGY
卷 26, 期 9, 页码 648-653

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.annepidem.2016.07.006

关键词

Physical function; Mobility; Aging; Physical activity; Muscle strength

资金

  1. National Cancer Institute [F31-CA192560, R21-CA182726, U54-CA155850]
  2. National Heart, Lung, and Blood Institute [F31-HL127947]
  3. National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [F32-DK096758]

向作者/读者索取更多资源

Purpose: The muscle quality index (MQI) was proposed as a measure to quantify age-related alterations in muscle function. It is unknown if the MQI predicts mortality. Methods: This was a population-based cohort study from the Third National Health and Nutrition Survey (NHANES III; 1988-1994). The MQI was quantified using a timed sit-to-stand test, body mass, and leg length. Vital status was obtained through the National Center for Health Statistics. We fit multivariable-adjusted regression models to estimate the hazard ratio (HR) and 95% confidence interval (CI) between the MQI and mortality. Results: During 14.6 years of follow-up, 3299 (73.1%) of 4510 study participants died. Lower MQI was associated with a higher risk of mortality (P-trend <.001). The multivariable-adjusted HR for mortality was 1.50 (95% CI, 1.15-1.96) for those in the lowest quintile of MQI compared to the highest quintile. The association between MQI and mortality was stronger among males (highest vs. lowest quintile of MQI, HR = 1.37 [95% CI, 1.00-1.87]; P-trend =.001) compared to females (highest vs. lowest quintile of MQI, HR = 1.27 (95% CI, 0.89-1.83); P-trend =.044; P-interaction =.005]. Conclusions: The MQI predicts mortality and may differ between males and females. Additional research examining the MQI is warranted. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Public, Environmental & Occupational Health

IJE's Education Corner turns 10! Looking back and looking forward

Michael O. Harhay, Katy J. L. Bell, Jonathan Y. Huang, Onyebuchi A. Arah

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Estimands in cluster-randomized trials: choosing analyses that answer the right question

Brennan C. Kahan, Fan Li, Andrew J. Copas, Michael O. Harhay

Summary: This article discusses the different estimands targeted in cluster-randomized trials (CRTs) and how the choice of analytic approach can impact the interpretation of results. The study findings highlight the potential bias introduced by common estimators when cluster size is informative, and propose alternative estimators that provide unbiased estimates even in the presence of informative cluster size.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Epidemiology, risk factors, and outcomes of lung retransplantation: An analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant Registry

Michael O. Harhay, Wida S. Cherikh, Alice E. Toll, Jason D. Christie, Josef Stehlik, Daniel Chambers, Don Hayes Jr, Edward Cantu

Summary: Lung retransplantation is a complex surgical decision that represents the only potential treatment option for recipients suffering from lung allograft failure. This study examined the modern landscape of lung retransplantation and found that the duration of time since the primary lung transplant was the strongest prognostic factor for 1-year mortality in retransplant recipients.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

The International thoracic organ transplant registry of the international society for heart and lung transplantation: Twenty-fifth pediatric heart transplantation report-2022; focus on infant heart transplantation

Tajinder P. Singh, Wida S. Cherikh, Eileen Hsich, Michael O. Harhay, Don Hayes, Michael Perch, Luciano Potena, Aparna Sadavarte, Andreas Zuckermann, Josef Stehlik

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease

Eileen Hsich, Tajinder P. Singh, Wida S. Cherikh, Michael O. Harhay, Don Hayes, Michael Perch, Luciano Potena, Aparna Sadavarte, Kelsi Lindblad, Andreas Zuckermann, Josef Stehlik

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth pediatric lung transplantation report-2022; focus on pulmonary vascular diseases

Don Hayes, Wida S. Cherikh, Michael O. Harhay, Michael Perch, Eileen Hsich, Luciano Potena, Aparna Sadavarte, Anne Zehner, Tajinder P. Singh, Andreas Zuckermann, Josef Stehlik

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients

Thomas C. Hanff, Adeline Browne, Jacqueline Dickey, Holly Gaines, Michael O. Harhay, Matt Goodwin, Craig H. Selzman, James C. Fang, Stavros G. Drakos, Josef Stehlik

Summary: Among Status 2 patients for heart transplantation, those supported with intra-aortic balloon pump (IABP) had lower risk of waitlist mortality compared to patients with ventricular tachycardia/fibrillation (VT/VF), right-or-biventricular assist device configurations, or temporary surgical left ventricular assist devices (LVADs).

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction

Wai Wong, Brandy Johnson, Pi Chun Cheng, Maureen B. Josephson, Katsuhide Maeda, Robert A. Berg, Steven M. Kawut, Michael O. Harhay, Samuel B. Goldfarb, Nadir Yehya, Adam S. Himebauch

Summary: This study aimed to investigate the impact of grade 3 PGD within 48 or 72 hours on CLAD-free survival following pediatric lung transplantation. The study found that the occurrence of grade 3 PGD within 48 or 72 hours was associated with shorter CLAD-free survival, and gender may be a modifier of this association.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Public, Environmental & Occupational Health

A Bayesian Approach for Estimating the Survivor Average Causal Effect When Outcomes Are Truncated by Death in Cluster-Randomized Trials

Guangyu Tong, Fan Li, Xinyuan Chen, Shashivadan P. Hirani, Stanton P. Newman, Wei Wang, Michael O. Harhay

Summary: Many studies face challenges with clustering and nonmortality outcomes that are truncated due to death. Traditional missing-data methods and causal estimands are not ideal for statistical inference in the presence of these issues. We developed a Bayesian estimator using principal stratification to address these problems and provide a causal interpretation of the treatment effect. Our simulation and reanalysis of a clinical trial showed promising results. Assessing the SACE estimand in studies with clustering and informative truncation can offer valuable insights into a subset of study participants.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Mathematical & Computational Biology

Leveraging baseline covariates to analyze small cluster-randomized trials with a rare binary outcome

Angela Y. Y. Zhu, Nandita Mitra, Karla Hemming, Michael O. O. Harhay, Fan Li

Summary: Cluster-randomized trials (CRTs) involve randomizing entire groups of participants-called clusters-to treatment arms but are often comprised of a limited or fixed number of available clusters. Analytical methods for individual-level covariate adjustment in small CRTs have received little attention to date. In this paper, we systematically investigate the operating characteristics of two individual-level covariate adjustment strategies and the uncertainty in estimating the participant-average treatment effect.

BIOMETRICAL JOURNAL (2023)

Article Multidisciplinary Sciences

Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia

Bryan S. Blette, Anders Granholm, Fan Li, Manu Shankar-Hari, Theis Lange, Marie Warrer Munch, Morten Hylander Moller, Anders Perner, Michael O. Harhay

Summary: The recommended dose of dexamethasone for severe or critical COVID-19 patients is currently 6 mg per day. However, personalized dosing may be more optimal due to the heterogeneity of these patients. A study comparing 6 mg/d to 12 mg/d of dexamethasone found that the higher dose was associated with better long-term outcomes, particularly in certain patient subgroups. This suggests that using 12 mg/d of dexamethasone could be beneficial for most patients and further research is needed to optimize dosing.

SCIENTIFIC REPORTS (2023)

Article Pharmacology & Pharmacy

Effects of duration of follow-up and lag in data collection on the performance of adaptive clinical trials

Anders Granholm, Theis Lange, Michael O. Harhay, Aksel Karl Georg Jensen, Anders Perner, Morten Hylander Moller, Benjamin Skov Kaas-Hansen

Summary: The performance of adaptive clinical trial designs can be affected by different outcome-data lags. Longer outcome-data lags or faster inclusion rates generally lead to poorer performance metrics.

PHARMACEUTICAL STATISTICS (2023)

Letter Respiratory System

Elements of Statistical Power in Pediatric Critical Care Trials

Bhavesh Patel, Hugues Yver, Charlotte Z. Woods-Hill, Michael O. Harhay, Nadir Yehya

ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)

Article Mathematical & Computational Biology

A mixed model approach to estimate the survivor average causal effect in cluster-randomized trials

Wei Wang, Guangyu Tong, Shashivadan P. Hirani, Stanton P. Newman, Scott D. Halpern, Dylan S. Small, Fan Li, Michael O. Harhay

Summary: In many medical studies, missing data due to death or dropout pose challenges in estimating treatment effects. This study proposes a mixed model approach and algorithm to estimate the survivor average causal effect (SACE) in cluster-randomized trials, filling the gap in existing methods.

STATISTICS IN MEDICINE (2023)

暂无数据